London R S, Sundaram G S, Goldstein P J
Obstet Gynecol. 1982 Apr;59(4):519-23.
As a primary care physician for women, the gynecologist frequently is faced with management of patients who have benign breast disease. Mammary dysplasia, or fibrocystic disease, clinically presents a difficult management problem, both in terms of relieving the patients' symptomatology and of detecting occult malignancy. Traditionally, diuretics, salt restriction, and hormone therapies have been recommended. Recently, data concerning nutritional impact on this disease process, including methylxanthine restriction and tocopherol therapy, have been reported. New, effective pharmacologic agents also are now available. This article reviews the efficacy of these therapeutic regimens and recommends a rational approach for the management of patients with mammary dysplasia.
作为一名女性初级保健医生，妇科医生经常面临患有良性乳腺疾病患者的管理问题。乳腺发育异常，即纤维囊性疾病，在缓解患者症状和检测隐匿性恶性肿瘤方面，临床上都存在难以解决的管理问题。传统上，人们推荐使用利尿剂、限制盐分摄入和激素疗法。最近，有关于营养对这一疾病进程影响的数据被报道，包括限制甲基黄嘌呤和生育酚疗法。现在也有了新的、有效的药物。本文回顾了这些治疗方案的疗效，并推荐了一种合理的方法来管理乳腺发育异常的患者。
